tiprankstipranks

Serge Belanger Profile - Needham Analyst

235 Followers
tipranks
Serge Belanger

Serge Belanger
Needham

Wall Street Analyst
#1,106 out of 12,287 Wall Street Analysts
#2,602 out of 28,757 experts

Success Rate

46%
229 out of 503 ratings made a profit

Average Return

+11.20%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Serge Belanger's trades since 2016 and holding each position for 1 Year would result in 45.53% of your transactions generating a profit, with an average return of 11.2% per rating.

Stock Rating Distribution

1KRatings
81.37% Buy
18.63% Hold
0.00% Sell
Distribution of Serge Belanger's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United States

Best Rating

Stock:
Arcutis Biotherapeutics Inc
(ARQT)
Rating:Buy
Date:Dec 18, 2023 - Dec 18, 2024
Return:+427.50%
The most profitable rating made by Serge Belanger

Serge Belanger's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Altamira Therapeutics
Aug 19, 2016
Buy
Reiterated
$5.00
(6393.51% Upside)
3Ratings
0.00%
Evofem Biosciences
Jun 26, 2017
Hold
Reiterated
2Ratings
0.00%
Greenidge Generation Holdings
Nov 05, 2021
Buy
Reiterated
$22.00
(1337.91% Upside)
1Ratings
0.00%
Akebia Therapeutics
Oct 28, 2022
Hold
Assigned
9Ratings
0%
-67.15%
CalciMedica
Oct 28, 2022
Hold
Assigned
13Ratings
0.00%
Clearside Biomedical
Dec 23, 2025
Hold
Assigned
48Ratings
20%
-23.77%
Pacira Pharmaceuticals
May 01, 2026
Buy
Reiterated
$32.00
(43.37% Upside)
78Ratings
18%
-17.79%
Viridian Therapeutics
May 05, 2026
Buy
Reiterated
$32.00
(95.72% Upside)
34Ratings
26%
-5.20%
Ocular Therapeutix
May 05, 2026
Buy
Reiterated
$18.00
(115.57% Upside)
13Ratings
30%
-9.87%
Evolus
May 05, 2026
Hold
Reiterated
29Ratings
33%
-13.60%
List of latest recommendations made by Serge Belanger. Click to expand and see Serge Belanger's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Serge Belanger activity FAQ

What is the performance of Serge Belanger's recommendations?
The percentage of profitable recommendations made by Serge Belanger is 46%, and the average return per transaction is 11.20%.
    What stocks does Serge Belanger cover?
    Serge Belanger mostly covers COLL ,PCRX ,LQDA stocks.
      What was Serge Belanger's most profitable rating?
      Serge Belanger’s most profitable ratings was a buy on ARQT stock on Dec 18, 2023 - Dec 18, 2024. The return on the trade was +427.50%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here